News for Emergent BioSolutions Inc. (ER4.F)

Texas, March 02, 2021 (GLOBE NEWSWIRE) -- The growth of this market is primarily due to the high prevalence of infectious diseases, increased government ...

24/7 Wall St. looks at some big analyst calls that we have seen so far on Wednesday, including Abercrombie & Fitch, Mattel, Radius Health and Western Digital.

Pune, India, Feb. 23, 2021 (GLOBE NEWSWIRE) -- The global animal health market size is anticipated to reach USD 67.56 billion by 2026 owing to the ...

Top Players Covered in the Animal Health Market Research Report are Emergent BioSolutions, Inc., Boehringer Ingelheim International GmbH, Novartis AG, Virbac, Intervet Inc., Bayer AG, Zoetis, Ceva, Merck & Co., Inc., IDEXX Laboratories, Inc., CSL Limited, Elanco and other key market players

24/7 Wall St. looks at some big analyst calls that we have seen so far on Friday, including Crocs, Emergent Bio, Macy’s and more.

Emergent BioSolutions Inc. (NYSE:EBS) Q4 2020 Earnings Conference Call February 18, 2021 05:00 p.m.

Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200 CIK : ...

Pune, India, Feb. 18, 2021 (GLOBE NEWSWIRE) -- The global vaccines market size is expected to be USD 93.08 billion by 2026, exhibiting a CAGR of 10.7% ...

The European Union has set a target of vaccinating 70% of its adult population by the end of the summer, but has struggled to secure the doses promised by pharmaceutical companies.

Exclusive: EU seeks new COVID-19 vaccine deal with Moderna, AstraZeneca flags doses made outside EU - sources

Biotech stocks advanced in the week ended Feb. 12, thanks to broader market strength and company-specific catalysts. Small and mid-cap earnings, m...

Biotech stocks advanced in the week ended Feb. 12, thanks to broader market strength and company-specific catalysts. Small and mid-cap earnings, multiple ...

AstraZeneca’s CEO promised more shots, at a lower price, than competitors, but now faces criticism from the EU for a production shortfall.

AstraZeneca’s CEO promised more shots, at a lower price, than competitors, but now faces criticism from the EU for a production shortfall.

Shares of Humanigen Inc. undefined were down 2.5% in trading on Monday after it announced a contract development and manufacturing deal with Emergent...

Anticipating strong economic and earnings gains in 2021 after the COVID-inspired recession in 2020, broad stock indices continued their hefty rally in 2020’s fourth quarter.